Clinical & Scientific Publications

Overall Survival and Quality of Life of Glioblastoma Patients According to MGMT Methylation Status: Real- World Data Analysis

Poster at ISPOR EU (2024)

Leveraging real-world data from multiple institutions to assess the rate of bilateral mastectomy after cancer genetics evaluations with genetic counselors.

Abstract at ASCO (2024)

Leveraging real-world data from multiple institutions to assess uptake of risk-reducing salpingo-oophorectomy after cancer genetic counseling

NSGC Annual Conference (2024)

A Health Care Clinical Data Platform for Rapid Deployment of Artificial Intelligence and Machine Learning Algorithms for Cancer Care and Oncology Clinical Trials

xPedite: A Study to Expedite DIPG and DMG research

Poster at ISPNO (2024)

Leveraging real-world data from multiple institutions to assess the rate of bilateral mastectomy after cancer genetics evaluations with genetic counselors

Abstract at ASCO (2024)

Use of a nationwide, patient-powered observational platform to define the landscape of treatment, molecular profiling, and outcomes for fibrolamellar carcinoma

Abstract at ASCO (2024)

Proton pump inhibitors are detrimental to overall survival of patients with GBM: results from a nationwide Real-World Evidence database

Neuro-Oncology Practice (2024)

An atlas of causal and mechanistic drivers of interpatient heterogeneity in glioma

MedRxiv (2024)

Efficacy of immune checkpoint inhibitors in glioblastoma from real world data analysis

Poster at SNO (2023)

AI-Augmented Clinical Decision Support in a Patient-Centric Precision Oncology Registry

AI in Precision Oncology (2023)

Tumor Treating Fields: Real-World Survival and Quality of Life Outcomes on the XCELSIOR Platform

Neuro-Oncology (2023)

Clinical utility of an international multidisciplinary virtual tumor board for fibrolamellar carcinoma.

Abstract at ASCO 2023

Use of proton pump inhibitors (PPI) in glioblastoma (GBM) and relationship to overall survival in a national real-world evidence (RWE) database.

Abstract at ASCO 2023

Real-World Quality-of-Life and Health Utilities for Patients with CNS Cancers on the xCELSIOR Platform

Neuro-Oncology (2022)

Updated clinical outcomes from ULI-EAP-100, an intermediate expanded access program for ulixertinib (BVD-523)

Journal of Clinical Oncology (2022)

Systems biology based therapeutic predictions with gbmSYGNAL and clinical correlates in the real world longitudinal outcomes registry XCELSIOR

Poster at SNO (2022)

Virtual Trials: Causally-validated treatment effects efficiently learned from an observational brain cancer registry

Artificial Intelligence in Medicine (2022)

Real world clinical outcomes of patients with diffuse midline glioma in a longitudinal outcomes registry

Poster at SNO (2022)

Case report: response to the ERK1/2 inhibitor ulixertinib in BRAF D594G cutaneous melanoma

Melanoma Research (2022)

Application of XCELSIOR, a nationwide real-world observational research protocol, to identify efficacious targeted therapy regimens in advanced pancreatic adenocarcinoma.

Abstract at ASCO (2022)

Cancer Commons’ Virtual Tumor Board program- a patient-centric advisory panel and Real-World Data registry.

Poster at ASCO GI (2022)

XCELSIOR: A real-time, real-world learning platform for patients with advanced cancer.

Poster at SNO Meeting (2021)

Use of a real-world data registry to rapidly generate outcomes data following a case study of a novel treatment combination in pancreatic adenocarcinoma

Poster at AACR (2020)

A Multilevel Model for Precision Oncology

Poster at ProgProb (2020).

Is Cancer Solvable? Towards Efficient and Ethical Biomedical Science

In the Journal of Law, Medicine & Ethics (2019).

Prototyping a precision oncology 3.0 rapid learning platform

In BMC Bioinformatics (2018).

Paths to Precision Medicine

In the Journal of Precision Medicine (2015).

Rapid learning for precision oncology

In Nature Reviews Clinical Oncology (2014).

Theoretical Issues for Global Cumulative Treatment Analysis (GCTA)

In arXiv (2013).

A novel classification of lung cancer into molecular subtypes

In PLOS One (2012).

A melanoma molecular disease model

In PLOS One (2011).